PLXNA3 and polycystic ovary syndrome: The aim of this investigation, was to evaluate the EA effects on blood glucose, insulin resistance, lipid profile, oxidative stress status, inflammatory factors, sex hormone levels and anti-mullerian hormone in women with PCOS.